As of 2025-07-04, the Intrinsic Value of Sophiris Bio Inc (SPHS) is -1.13 USD. This SPHS valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Sophiris Bio Inc is -112,550,100.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Sophiris Bio Inc (SPHS) is overvalued by 112,550,100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.13 - -1.13 | -1.13 | -112,550,100.00% |
| DDM - Stable | 0.00 - 0.00 | 0.00 | 4376.0% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -14719.8% |
| Market Cap (mil) | 0.00 |
| Beta | 1.78 |
| Outstanding shares (mil) | 34.47 |
| Enterprise Value (mil) | 1.50 |
| Market risk premium | 4.24% |
| Cost of Equity | 147,062.00% |
| Cost of Debt | 5.00% |
| WACC | 4.37% |